Reviva Pharmaceuticals Holdings, Inc. SC 13G and SC 13G/A reports

Location
10080 N Wolfe Road, Suite Sw3 200, Cupertino, California
State of incorporation
Delaware
Fiscal year end
December 31
Data updated at
6/1/2024, 01:28 AM
Form type Sec Links Description Filing date Reporting date
SC 13G/A Report AMENDMENT NO. 2 Feb 14, 2024
SC 13G Report Feb 14, 2024
SC 13G/A Report AMENDMENT NO. 1 Feb 14, 2023
SC 13G/A Report SABBY 13G-A RVPH 1.05.22 Jan 5, 2022
SC 13G Report Jun 3, 2021
SC 13G/A Report TZAC 13GA Jan 8, 2021
SC 13G/A Report SABBY 13G-A RVPH 1.07.21 Jan 7, 2021
SC 13G Report SABBY 13G TZAC 12.18.20 Dec 18, 2020
SC 13G/A Report TZAC 13GA Nov 4, 2020
SC 13G Report Oct 13, 2020
SC 13G Report SCHEDULE 13G Feb 14, 2020
SC 13G/A Report Feb 13, 2020
SC 13G Report Apr 2, 2019
SC 13G Report Feb 14, 2019
SC 13G/A Report Feb 13, 2019
SC 13G Report TZACU 13G Feb 5, 2019
SC 13G Report Aug 28, 2018